KB803

· Krystal Biotech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KB803, covering 2026-03-12 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa [Phase 3]